流感嗜血桿菌血清學(xué)診斷方法

廣州健侖生物科技有限公司

我司還有很多種血清學(xué)診斷血清、血液檢測、免疫檢測產(chǎn)品、毒素檢測、凝集檢測、酶免檢測、層析檢測、免疫熒光檢測產(chǎn)品，。

（ MOB：楊永漢）

【流感知識(shí)】

流感嗜血桿菌是一種沒有運(yùn)動(dòng)力的革蘭氏陰性桿菌。它是于1892年由費(fèi)佛博士在流行性感冒的瘟疫中發(fā)現(xiàn)。它一般都是好氧生物，但可以成長為兼性厭氧生物。
流感嗜血桿菌zui初被誤認(rèn)為是流行性感冒的病因，但直至1933年，當(dāng)發(fā)現(xiàn)流行性感冒的病毒性病原后，才消除了這種誤解。不過，流感嗜血桿菌仍會(huì)導(dǎo)致其他不同種類的病癥。  

本試劑盒主要用于對病菌細(xì)菌進(jìn)行檢測，利用快速玻片凝集檢測技術(shù)

嗜血桿菌屬血清群A型鑒定

嗜血桿菌屬血清群A型鑒定

嗜血桿菌屬血清群A型鑒定

嗜血桿菌屬血清群A型鑒定

流感嗜血桿菌A/B型凝集抗血清Haemophilus

流感嗜血桿菌A/B型凝集抗血清Haemophilus

流感嗜血桿菌A/B/C型血清群

流感嗜血桿菌A/B/C型血清群

流感嗜血桿菌A/B/C3型凝集抗血清

流感嗜血桿菌A/B/C3型凝集抗血清

a型流感嗜血桿菌診斷血清

a型流感嗜血桿菌診斷血清

玻片凝集法鑒定流感嗜血桿菌

玻片凝集法鑒定流感嗜血桿菌

b型2ml流感嗜血桿菌快速玻片法檢測血清

b型2ml流感嗜血桿菌快速玻片法檢測血清

A型、B型流感嗜血桿菌多群血清

A型、B型流感嗜血桿菌多群血清

流感嗜血桿菌血清群b型鑒定

流感嗜血桿菌血清群b型鑒定

夾饃型流感嗜血桿菌血清群

夾饃型流感嗜血桿菌血清群

流感嗜血桿菌血清學(xué)診斷方法

我司還提供其它進(jìn)口或國產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細(xì)菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

想了解更多的產(chǎn)品及服務(wù)請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】    楊永漢

【】 
【騰訊  】 
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號二期2幢101-103

細(xì)胞的細(xì)胞膜上有許多不同的標(biāo)志，主要是表 面抗原和表面受體。這些表面標(biāo)志都是結(jié)合在細(xì)胞膜上的巨蛋白 分子。T淋巴細(xì)胞(T lymphocyte)簡稱T細(xì)胞，是由來源于骨髓的 淋巴干細(xì)胞，在胸腺中分化、發(fā)育成熟后，通過淋巴和血液循環(huán) 而分布到全身的免疫和組織中發(fā)揮免疫功能[1]  。T淋巴細(xì)胞的 發(fā)育、分化多能干細(xì)胞轉(zhuǎn)變?yōu)榱馨蜆忧绑w細(xì)胞(Lymphoid  precursor)遷移至胸腺，在胸腺素的誘導(dǎo)下，經(jīng)歷一系列有序的 分化過程，逐漸在胸腺發(fā)育成熟為識(shí)別各種抗原的T細(xì)胞庫。T淋 巴細(xì)胞進(jìn)入胸腺后首先經(jīng)歷兩個(gè)階段：①早期T淋巴細(xì)胞發(fā)育階段 ，即始祖CIM和CD8雙性T淋巴細(xì)胞(double negative cell，DN) 分化為CD4和CD8雙陽性T細(xì)胞(double positive cell，DP)；② DP細(xì)胞分別經(jīng)歷陽性選擇階段和性選擇階段獲取MHC限制性識(shí)別能 力和對自身抗原的耐受性，發(fā)育為其表面標(biāo)志為CD4或CD8的單陽 性T細(xì)胞(single positive cell，SP)，遷往周圍淋巴定居[2]   。分類T細(xì)胞是相當(dāng)復(fù)雜的不均一體、又不斷在體內(nèi)更新、在同一 時(shí)間可以存在不同發(fā)育階段或功能的T淋巴細(xì)胞T淋巴細(xì)胞亞，但 分類原則和命名比較混亂，尚未統(tǒng)一。按免疫應(yīng)答中的功能不同 ，可將T細(xì)胞分成若干亞，**的有：輔助性T細(xì)胞（Helper  T cells,Th），具有協(xié)助體液免疫和細(xì)胞免疫的功能。
There are many different markers on the cell membrane of cells, mainly surface antigens and surface receptors. These surface markers are megalin molecules bound to the cell membrane. T lymphocytes (T lymphocytes) are abbreviated as T cells, and they are bone marrow-derived lymphatic stem cells. After differentiation and maturation in the thymus, they exert immune functions through lymphatic and blood circulation and distribution throughout the body's immunity and tissues [1]. The development and differentiation of T lymphocytes The pluripotent stem cells are transformed into Lymphoid precursors and migrate to the thymus. Under the induction of thymosin, they undergo a series of ordered differentiation processes and gradually develop in the thymus to identify various T cell library of antigens. T lymphocytes enter the thymus first go through two stages: 1 early T lymphocyte development stage, namely the ancestor CIM and CD8 bisexual T lymphocytes (double negative cell, DN) differentiation into CD4 and CD8 double positive T cells (double positive cell (DP);2 DP cells undergo positive selection phase and sexual selection phase to acquire MHC restriction recognition ability and tolerance to self antigen, and develop single positive cells with surface markers CD4 or CD8. SP), relocate to peripheral lymphoid [2]. The classifying T cells are rather complex and heterogeneous, and they are continuously updated in vivo, and T lymphocyte sub-lymphocytes of different developmental stages or functions can be present at the same time. However, the classification principles and naming are confusing and have not been unified. According to the different functions in the immune response, T cells can be divided into several sub-areas. It is generally accepted that helper T cells (Th) have the function of assisting humoral immunity and cellular immunity.